This inventor holds 1 USPTO granted patent. Top assignees: Epivax, Inc., Innatoss Laboratories B.v., The General Hospital Corporation. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 22 
1 out of 2 
1 out of 3,076 
Years Active: 2023
Title: Ann Elizabeth Sluder: Innovator in Vaccine Development
Introduction
Ann Elizabeth Sluder is a notable inventor based in Bedford, Massachusetts. She has made significant contributions to the field of immunology, particularly in the development of vaccines. Her work focuses on enhancing protective immune responses against infectious diseases.
Latest Patents
Ann holds a patent for "epitopes for T cell-targeted Q fever vaccines." This patent encompasses compositions and methods aimed at inducing a protective immune response to reduce the risk of developing Q fever in subjects. Her innovative approach highlights the importance of targeted vaccine development in combating infectious diseases.
Career Highlights
Throughout her career, Ann has worked with reputable organizations, including The General Hospital Corporation and Epivax, Inc. These experiences have allowed her to collaborate with leading experts in the field and contribute to groundbreaking research in vaccine technology.
Collaborations
Ann has collaborated with esteemed colleagues such as Mark C. Poznansky and Timothy Alan Brauns. Their joint efforts have further advanced the understanding and development of effective vaccines.
Conclusion
Ann Elizabeth Sluder's contributions to vaccine development exemplify her dedication to improving public health through innovative research. Her work continues to inspire future advancements in immunology and vaccine technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile